SEL120-34A monohydrochloride (C007B-419182)

SEL120-34A monohydrochloride is an ATP-competitive and selective CDK8 inhibitor, inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC 50 s of 4.4 nM and 10.4 nM, respectively, with a K d of 3 nM for CDK8 . SEL120-34A monohydrochlorideAppearance:SolidIC50& Target:CDK8/CycC 4.4 nM (IC 50 ) CDK19/CycC 10.4 nM (IC 50 ) CDK9/cycT 1070 nM (IC 50 )In Vitro:SEL120-34A monohydrochloride is an ATP-competitive and selective CDK8 inhibitor, inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC 50 s of 4.4 nM and 10.4 nM, respectively, with a K d of 3 nM for CDK8. SEL120-34A monohydrochloride wIn Vivo:SEL120-34A monohydrochloride (30, 60mg/kg, p.o. once every day) inhibits growth of AML tumors in a dose-dependent manner in SCID mice after treatment for 17 days. MCE has not independently confirmed the accuracy of these methods. They are for refereBiological Activity:SEL120-34A monohydrochloride is an ATP-competitive and selective CDK8 inhibitor, inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC 50 s of 4.4 nM and 10.4 nM, respectively, with a K d of 3 nM for CDK8 . SEL120-34A monohydrochloride.

Specifications and Purity: ≥98%

Molecular Formula: C15H19Br2ClN4

Molecular Weight: 450.6